Bacterial glycosylation

Show results for

Unknown (543)
Proteomics (87)
Transcriptomics (51)
Genomics (28)
Metabolomics (6)

Organisms

Bombyx mori (74)
Onchocerca volvulus (74)
Mus musculus (21)
Homo sapiens (13)
Solea senegalensis (2)
Streptococcus agalactiae (2)
Vibrio cholerae (2)
Danio rerio (2)
Campylobacter jejuni subsp. jejuni NCTC 11168 = ATCC 700819 (1)
Salmonella enterica subsp. enterica (1)
Pinus radiata (1)
Aspergillus niger (1)
Clostridium botulinum (1)
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 (1)
Listeria monocytogenes (1)
Campylobacter jejuni (1)
Trypanosoma brucei (1)
Helicobacter pylori (1)
Anopheles gambiae (1)
Salmonella enterica subsp. enterica serovar Typhimurium (1)
Escherichia coli K-12 (1)
Saccharomyces cerevisiae (1)
Escherichia coli str. K-12 substr. MG1655 (1)
Rattus norvegicus (1)
Drosophila melanogaster (1)
Arabidopsis thaliana (1)
Staphylococcus aureus (1)
Sus scrofa (1)
Caenorhabditis elegans (1)
Alistipes onderdonkii (1)

Organisms

Mus musculus (2)
Campylobacter jejuni subsp. jejuni (1)
Danio rerio (1)
Caenorhabditis elegans (1)
Sus scrofa (1)
mouse gut metagenome (1)
Staphylococcus aureus (1)
Homo sapiens (1)

Repository

pride (74)
biostudies-arrayexpress (51)
ENA (19)
MassIVE (11)
geo (10)
MetaboLights (5)
iProX (2)
GNPS (1)

Tissue

Blood plasma (5)
Cell culture (4)
Colon (3)
Early embryonic cell (2)
Feces (2)
Blood serum (2)
Epithelial cell (2)
Liver (2)
Crypt of Lieberkuhn of colon (1)
Colonic mucosa (1)
Hemolymph (1)
Intestinal epithelium (1)
Saliva (1)
Blood (1)
Ascites (1)
Cell suspension culture (1)
T cell (1)
Brain (1)
Kidney (1)
Whole body (1)

Disease

Disease free (2)
Neuroblastoma (1)
Intestinal infectious disease (1)
Septic shock (1)
Congenital disorder of glycosylation (1)
Bacterial sepsis (1)
COVID-19 (1)
Obesity (1)
Type 2 diabetes mellitus (1)
Colon cancer (1)

Technology Type

Mass Spectrometry (74)
Shotgun proteomics (35)
Bottom-up proteomics (22)
Data-dependent acquisition (9)
Gel-based experiment (8)
Affinity purification coupled with mass spectrometry proteomics (5)
Mass spectrometry (3)
Glycoproteomics (3)
Top-down proteomics (3)
Mass spectrometry assay (2)
Data-independent acquisition (2)
SWATH MS (2)
Affinity proteomics (1)
DiaPASEF (1)
All-ion fragmentation (1)

Instrument Platform

NextSeq 500 (7)
Orbitrap Eclipse (3)
Liquid Chromatography MS - negative - reverse phase (3)
Liquid Chromatography MS - positive - reverse phase (3)
LTQ Orbitrap (2)
Orbitrap Exploris 480 (2)
Q Exactive Plus (2)
Liquid Chromatography MS - negative (2)
Liquid Chromatography MS - positive (2)
GeneQuant DNA/RNA caluculator (1)
Variable Atmosphere Incubator (1)
Illumina MiSeq (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 2000 (1)
Illumina HiSeq 3000 (1)
Q Exactive (Thermo Scientific instrument model HF) (1)
LTQ Orbitrap Velos Pro (1)
TimsTOF Pro (1)
Q Exactive (1)
Q Exactive HF (1)

Publication Date

2025 (19)
2022 (17)
2024 (16)
2026 (14)
2020 (12)
2023 (9)
2021 (8)
2019 (7)
2010 (7)
2015 (6)
2013 (6)
2012 (5)
2014 (4)
2011 (4)
2008 (4)
2009 (3)
2005 (3)
2018 (3)
2017 (2)
2007 (1)
2006 (1)
2016 (1)

CHEBI ID

CHEBI:145681 (1)
CHEBI:141463 (1)
CHEBI:87766 (1)
CHEBI:16914 (1)
CHEBI:17964 (1)

Metabolite Name

Thr-Tyr-Asp-Arg-Asn (1)
[(2R,3S,4S,5R)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-[[(E)-2-methylbut-2-enoyl]oxymethyl]-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl (E)-2-methylbut-2-enoate (1)
[Met5,Lys6] alpha-Neo-Endorphin (1-6) (1)
2,4,5,6(1H,3H)-Pyrimidinetetrone,5-[2-(2-chlorophenyl)hydrazone] (1)
Bullatalicin (1)
2-docosanamidoethanesulfonic acid (1)
2,6,10,14-Tetramethyl-16-(5-methyl-3,6-dioxo-1,4-cyclohexadiene-1-yl)-2-hydroxy-6,10,14-hexadecatriene-3-one (1)
[(2S)-2-[9-(3,4-dimethyl-5-propylfuran-2-yl)nonanoyloxy]-3-hydroxypropyl] 11-(3,4-dimethyl-5-propylfuran-2-yl)undecanoate (1)
(2S,3R,4R,4aR,6aR,6bS,8aS,14bR)-2,3-dihydroxy-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylate (1)
[(2S)-2-hexadecanoyloxy-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropyl] (Z)-octadec-9-enoate (1)
[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-(3-methyl-5-pentylfuran-2-yl)propanoate (1)
(2R,3R,4R,5R)-2-[(9R)-9,13-dihydroxytridecyl]-5-(hydroxymethyl)pyrrolidine-3,4-diol (1)
(1S,4aS,10aR)-6-[(4bS,8S,8aR)-8-carboxy-2-hydroxy-4b,8-dimethyl-1-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl]-7-hydroxy-1,4a-dimethyl-8-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid (1)
NCGC00384622-01_C34H42O14_(1S,2S,4S,5R,6R,7S,9R,12R)-12-Acetoxy-6-(acetoxymethyl)-2-hydroxy-2,10,10-trimethyl-5-[(2-methylbutanoyl)oxy]-11-oxatricyclo[7.2.1.0~1,6~]dodecane-4,7-diyl di(3-furoate) (1)
(1'R,2R,3S,4'S,6S,8'R,10'E,12'S,13'S,14'E,16'E,20'R,21'R,24'S)-2-butan-2-yl-21',24'-dihydroxy-12'-[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-3,11',13',22'-tetramethylspiro[2,3-dihydropyran-6,6'-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene]-2'-one (1)
(4'Z,7'Z,10'Z,13'Z,16'Z,19'Z)-4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid, diester with 1,2,3-propanetriol (1)
3-Oxolanosta-7,24Z-dien-26-oic acid (1)
[(2R,3R)-5,7-dihydroxy-2-[3,4,6-trihydroxy-5-oxo-8-[(2R,3S)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]benzo[7]annulen-1-yl]-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate (1)
(Gal1-4GlcNAc)2-Sp (1)
Ala-Lys-Gly-Lys-Ser (1)
DTDP-4-keto-2-deoxy-beta-L-xylose (1)
Arg-Leu-Arg-Glu-Lys (1)
UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uloseuronic acid (1)
Hydrogen trioxo[3-(1lambdachromen-1-ylium-2-yl)phenoxy]-lambdasulfanuide (1)
(9R,10S,12S,13S,14R,16S,18R)-13-ethyl-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol (1)
Ser-Thr-Pro-Asp-Ala (1)
Phe-Gln-Phe-Phe-Lys (1)
Eoxin A4 (1)
Asn-His-Ile-Arg (1)
NCGC00380724-01_C28H47NO8_(3R,5R,6S,7S,9R,11E,13S,14R)-14-Ethyl-13-hydroxy-3,5,7,9,13-pentamethyl-2,4,10-trioxooxacyclotetradec-11-en-6-yl 3,4,6-trideoxy-3-(dimethylamino)-D-xylo-hexopyranoside (1)

First Public Date

2020 (4)
2025 (3)
2026 (2)
2022 (2)
2015 (2)
2014 (2)
2024 (1)
2023 (1)
2021 (1)
2017 (1)

Classification

bacteria (2)

Study type

Transcription profiling by array (32)
DNA-seq (4)
RNA-seq of coding RNA (4)
Unknown experiment type (2)
Methylation profiling by high throughput sequencing (2)
High-throughput sequencing (1)
Animal - High-throughput sequencing (1)
Comparative genomic hybridization by array (1)
ChIP-seq (1)
RNA-seq of coding RNA from single cells (1)
RNA-seq of non coding RNA (1)

Release Date

2025 (47)
2022 (43)
2015 (43)
2023 (42)
2020 (41)
2014 (38)
2021 (36)
2017 (33)
2019 (32)
2024 (31)
2018 (30)
2011 (26)
2016 (25)
2012 (24)
2010 (21)
2013 (20)
2008 (16)
2009 (13)
2007 (11)
2026 (6)
2006 (4)
2005 (4)
2003 (3)
2001 (3)
2002 (2)

Lab affiliation

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for infection and immunity, Melbourne, 3000, Australia (10)
Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne 3000, Australia (7)
Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia (5)
Department of Oral Biology and Pathology, Faculty of Odontology, Malmö University, Malmö, Sweden (2)
Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands (1)
Department of Microbiology & Molecular Medicine and Geneva Center for Inflammation Research (GCIR), Faculty of Medicine, University of Geneva, Rue Michel Servet 1, 1211 Genève 4, Switzerland. (1)
University of Oslo Faculty of Medicine Department of Microbiology (1)
ASTRE, Univ Montpellier, CIRAD, INRA, Montpellier, France & CIRAD, UMR ASTRE, F-34398, Montpellier, France (1)
Department of Biosciences, Center for Integrative Microbial Evolution, University of Oslo, Oslo, Norway, Centre for Ecological and Evolutionary Synthesis, University of Oslo, Oslo, Norway (1)
Department of Medical Biochemistry, University of Gothenburg (1)
Center for Biologics Evaluation and Research Division of Bacterial, Parasitic and Allergenic Products Food and Drug Administration (1)
Julian Langer: MPI for Biophysics and Brain Research Kate Heesom (k.heesom@bristol.ac.uk): University of Bristol Proteomics Facility (1)
Department of Biochemistry, Vanderbilt University, Nashville, TN, USA (1)
Institute for Glycomics, Gold Coast Campus, Griffith University, QLD 4222, Australia (1)
Université de Paris, Institut Cochin, Inserm, U1016, CNRS UMR8104, Paris, France (1)
Université catholique de Louvain, Louvain Drug Research Institute (LDRI), Metabolism and Nutrition Lab (MNut) (1)
1- Department of Biology, Faculty of Science, Erciyes University, Kayseri, Turkey 2- Genome and Stem Cell Center (GENKÖK) Erciyes University, Kayseri, Turkey (1)
Yale University, Department of Chemistry (1)
Division of Gastroenterology, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada. (1)
Stanford University, Department of Chemistry and ChEM-H, Stanford, CA Howard Hughes Medical Institute, Stanford, CA (1)
College of Veterinary Medicine, Kansas State University, Manhattan, KS, United States (1)
Center for Proteomics and Metabolomics, Leiden Universtity Medical Center, The Netherlands (1)
Melbourne Dental School, The University of Melbourne (1)
1 Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, 3584 CH Utrecht, the Netherlands 2 Netherlands Proteomics Center, Padualaan 8, 3584 CH Utrecht, the Netherlands (1)
LUMC (1)
Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia. (1)
Centro de Análises Proteômicas e Bioquímicas, Universidade Católica de Brasília, Brasília, Brazil. S-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, Brazil. (1)
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. (1)
Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville, Victoria 3010, Australia. (1)
Omniose/VaxNewMo, St. Louis, MO 63110 (1)

Previous page
1 / 72
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 72
Next page

Sort by:

Relevance

Page size

H. pylori G27 HP0518 mutant showed greater motility

Helicobacter pylori is a human gastric pathogen associated with gastric and duodenal ulcers as well as specific gastric cancers. It is well-evidenced that motility is essential for this pathogen to colonize human gastric tissues. We found that the H. pylori G27 HP0518 mutant showed greater motility ...

ORGANISM(S): Helicobacter pylori

2010-12-22 | E-GEOD-14752 | biostudies-arrayexpress

Arg-GlcNAcylation of GshB, An intra-bacterial activity for a T3SS effector

Many Gram-negative bacterial pathogens interact with mammalian cells by using type III secretion systems (T3SS) to inject virulence proteins directly into infected host cells. A subset of these injected protein ‘effectors’ are enzymes that modify the structure and inhibit the function of human prote...

ORGANISM(S): Escherichia coli

2020-01-14 | PXD015752 | Pride

Quantitative analyses reveal novel roles for N-glycosylation in a major enteric bacterial pathogen

In eukaryotes glycosylation plays a role in proteome stability, protein quality control and modulating protein function, however, similar studies in bacteria are lacking. Here, we investigate the role of general protein glycosylation systems in bacteria using the enteropathogen Campylobacter jejuni ...

ORGANISM(S): Campylobacter jejuni subsp. jejuni NCTC 11168 = ATCC 700819

2021-09-08 | PXD011452 | Pride

Glycosylation Tmt Quantitative proteomics Campylobacter

Transcription profiling of human congenital disorders of Glycosylation type-1 patients (CDG-I)

Disruption of N-linked glycosylation has a broad impact on proper glycosylation of nascent glycoproteins in the endoplasmic reticulum, which affect multiple signalling pathways( by changing the stability of membrane proteins or the signalling ability of membrane receptors) and may be responsible of ...

ORGANISM(S): Homo sapiens

2008-10-18 | E-GEOD-8440 | biostudies-arrayexpress

Glycosylation of bacterial antigens changes epitope patterns.

Not available

S-EPMC10637626 | biostudies-literature

Open database searching enables the identification and comparison of glycoproteomes without defining glycan compositions prior to searching

Mass spectrometry has become an indispensable tool for the characterisation of glycosylation across biological systems. Our ability to generate rich fragmentation data of glycopeptides has dramatically improved over the last decade yet our informatic approaches still lag be hide. This is especially ...

ORGANISM(S): Campylobacter fetus subsp. fetus Burkholderia cenocepacia J2315 Burkholderia pseudomallei (strain K96243) Acinetobacter baumannii

2020-06-24 | PXD018587 | Pride

Wide tolerant database searching Bacterial glycosylation Open searching Glycosylation Glycopeptides Post-translational modifications Proteomics Atypical glycosylation

Metabolic Glycan Labeling-Based Screen to Identify Bacterial Glycosylation Genes.

Not available

S-EPMC7808405 | biostudies-literature

Definition of the bacterial N-glycosylation site consensus sequence.

Not available

S-EPMC1456941 | biostudies-literature

Glycan-tailored glycoproteomic analysis reveals Serine is the sole residue subjected to O-linked glycosylation in Acinetobacter baumannii

Protein glycosylation is a ubiquitous process observed across all domains of life. Within the human pathogen Acinetobacter baumannii, O-linked glycosylation is required for virulence however the targets and conservation of glycosylation events remains poorly defined. Within this work we expand our u...

ORGANISM(S): Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841

2024-07-12 | PXD050066 | Pride

Glycosylation Acinetobacter baumannii Glycoproteomics Post-translational modifications Pgll

Plasma glycoproteomics delivers high-specificity disease biomarkers by detecting site-specific glycosylation abnormalities

The human plasma glycoproteome holds enormous potential to identify personalized biomarkers to diagnose and understand disease. Recent advances in mass spectrometry and software development are opening novel avenues to mine the glycoproteome for protein- and site-specific glycosylation changes. Here...

ORGANISM(S): Homo sapiens (Human)

2022-06-01 | PXD034214 | Pride

Glycoproteomics Plasma Glycopeptide Congenital disorders of glycosylation Blood

Previous page
1 / 72
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 72
Next page

Sort by:

Relevance

Page size

716 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Classification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets